Russell Frank Company’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
$29.5M Buy
788,631
+96,463
+14% +$3.61M 0.05% 421
2015
Q4
$30.4M Buy
692,168
+679,788
+5,491% +$29.8M 0.05% 390
2015
Q3
$464K Buy
12,380
+6,214
+101% +$233K ﹤0.01% 2491
2015
Q2
$210K Buy
6,166
+4,649
+306% +$158K ﹤0.01% 2796
2015
Q1
$54K Sell
1,517
-115,532
-99% -$4.11M ﹤0.01% 2801
2014
Q4
$4.08M Sell
117,049
-29,965
-20% -$1.04M 0.01% 1411
2014
Q3
$5.67M Sell
147,014
-112,613
-43% -$4.34M 0.01% 1203
2014
Q2
$10.1M Sell
259,627
-57,634
-18% -$2.24M 0.02% 913
2014
Q1
$12.6M Sell
317,261
-29,383
-8% -$1.17M 0.02% 758
2013
Q4
$9.16M Buy
346,644
+121,927
+54% +$3.22M 0.02% 901
2013
Q3
$5.82M Buy
224,717
+27,026
+14% +$700K 0.01% 1235
2013
Q2
$5.31M Buy
+197,691
New +$5.31M 0.01% 1204